Inventor
VÅGBERG JAN
SE9 patents
⚠️ This page may combine multiple inventors who share the name “VÅGBERG JAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KANCERA AB
8 patentsUS11691988B2Jul 4, 2023
Process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines and products obtainable therefrom
KANCERA AB2 citations68
US11339183B2May 24, 2022
Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1
KANCERA AB2 citations67
US12264165B2Apr 1, 2025
Process for the stereoselective preparation of chiral 2-[(hetero) arylalkylsulfanyl]pyrimidines and products obtainable therefrom
KANCERA AB0 citations58
US11542281B2Jan 3, 2023
Process for the steroselective preparation of chiral 2- [(hetero)arylalkylsulfanyl] pyrimidines and products obtainable therefrom
KANCERA AB0 citations58
US12060380B2Aug 13, 2024
Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1
KANCERA AB0 citations56
US11660303B2May 30, 2023
2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
KANCERA AB0 citations43
US11008318B2May 18, 2021
2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
KANCERA AB0 citations43
US10512634B2Dec 24, 2019
Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity
KANCERA AB0 citations34